Related Experiment Video
Updated: Nov 6, 2025

Animal Models of Depression - Chronic Despair Model CDM
Published on: September 23, 2021
Exo- and Endo-cannabinoids in Depressive and Suicidal Behaviors
Srinagesh Mannekote Thippaiah1,2, Sloka S Iyengar3, K Yaragudri Vinod4,5,6
1Valleywise Behavioral Health, Phoenix, AZ, United States.
Abstract:
Cannabis (marijuana) has been known to humans for thousands of years but its neurophysiological effects were sparsely understood until recently. Preclinical and clinical studies in the past two decades have indisputably supported the clinical proposition that the endocannabinoid system plays an important role in the etiopathogeneses of many neuropsychiatric disorders, including mood and addictive disorders. In this review, we discuss the existing knowledge of exo- and endo-cannabinoids, and role of the endocannabinoid system in depressive and suicidal behavior. A dysfunction in this system, located in brain regions such as prefrontal cortex and limbic structures is implicated in mood regulation, impulsivity and decision-making, may increase the risk of negative mood and cognition as well as suicidality. The literature discussed here also suggests that the endocannabinoid system may be a viable target for treatments of these neuropsychiatric conditions.
Related Concept Videos
Depressive Disorders: Etiology
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
Antidepressant Drugs: MAOIs and Other Agents
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
Two synthetic agonists of THC,...
G-protein Coupled Receptors
CNS Depressants: Alcohol and Nicotine

